Experiment 1136522
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | MARAL,R: MATHE,G: DANTCHEV,D: DELGADO,M: MACHOVER,D: TAPIERO,H: RIBAUD,P: MISSET,JL: GASTIABURU,J:. (1983). ACLACINOMYCIN A: PRESENT STATUS OF EXPERIMENTAL AND CLINICAL STUDIES.. 9(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II TRIAL,45 PATIENTS WITH LEUKEMIA WERE TREATED FOR 6-30 DAYS OF 19 PATIENTS WITH AML,THERE WERE 4 COMPLETE AND 3 PARTIAL REMISSIONS.THE 19 PATIENTS WITH ALL,AND THE II WITH LSL HAD 2 COMPLETE AND 2 PARTIAL REMISSIONS EACH. MYELOSUPPRESSION WAS SEVERE IN ALL PATIENTS AND 4 PATIENTS DIED WITH BONE MARROW APLASIA.THERE WAS HEMORRHAGIC DIARRHEA,NAUSEA AND/OR VOMITING,AND STOMATITIS.ABNORMAL ECG AND CONGESTIVE HEART FAILURE WAS SEEN IN 13 AND 4% OF THE CASES,RESPECTIVELY. |
| Dose amount | 10.30 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |